Michael D. Pak

Array ( [id] => 82209 [patent_doc_number] => 07745583 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'Anti-myostatin antibodies' [patent_app_type] => utility [patent_app_number] => 12/612060 [patent_app_country] => US [patent_app_date] => 2009-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 11 [patent_no_of_words] => 23551 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/745/07745583.pdf [firstpage_image] =>[orig_patent_app_number] => 12612060 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488642 [patent_doc_number] => 20110236912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'SYSTEMS AND METHODS FOR CHARACTERIZING LUPUS ERYTHEMATOSUS' [patent_app_type] => utility [patent_app_number] => 12/611711 [patent_app_country] => US [patent_app_date] => 2009-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8275 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236912.pdf [firstpage_image] =>[orig_patent_app_number] => 12611711 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7500647 [patent_doc_number] => 20110263046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Methods of identification of novel ligands for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (NR1F3) activity' [patent_app_type] => utility [patent_app_number] => 13/124860 [patent_app_country] => US [patent_app_date] => 2009-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8899 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0263/20110263046.pdf [firstpage_image] =>[orig_patent_app_number] => 13124860 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8932640 [patent_doc_number] => 08492339 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-07-23 [patent_title] => 'Angiogenesis promoted by caged growth factors' [patent_app_type] => utility [patent_app_number] => 12/605744 [patent_app_country] => US [patent_app_date] => 2009-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6748 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12605744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4433875 [patent_doc_number] => 07897731 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-01 [patent_title] => 'Corticotropin releasing factor 2 receptor agonists' [patent_app_type] => utility [patent_app_number] => 12/605718 [patent_app_country] => US [patent_app_date] => 2009-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21300 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/897/07897731.pdf [firstpage_image] =>[orig_patent_app_number] => 12605718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6228841 [patent_doc_number] => 20100183579 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-22 [patent_title] => 'MEMORY ENHANCING PROTEIN' [patent_app_type] => utility [patent_app_number] => 12/580782 [patent_app_country] => US [patent_app_date] => 2009-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5254 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20100183579.pdf [firstpage_image] =>[orig_patent_app_number] => 12580782 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7732400 [patent_doc_number] => 20120015387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'MARKER PEPTIDES FOR DETERMINING THE OCCURRENCE OF AN INFLAMMATORY STATE IN A SUBJECT' [patent_app_type] => utility [patent_app_number] => 13/123028 [patent_app_country] => US [patent_app_date] => 2009-10-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 18495 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20120015387.pdf [firstpage_image] =>[orig_patent_app_number] => 13123028 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6527954 [patent_doc_number] => 20100015114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-21 [patent_title] => 'PERIPHERAL-TYPE BENZODIAZEPINE RECEPTOR EXPRESSION LEVEL AS AN INDEX OF ORGAN DAMAGE AND REGENERATION' [patent_app_type] => utility [patent_app_number] => 12/569511 [patent_app_country] => US [patent_app_date] => 2009-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 10038 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20100015114.pdf [firstpage_image] =>[orig_patent_app_number] => 12569511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6374645 [patent_doc_number] => 20100081163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'ION CHANNEL ASSAY METHODS' [patent_app_type] => utility [patent_app_number] => 12/568604 [patent_app_country] => US [patent_app_date] => 2009-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 46727 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081163.pdf [firstpage_image] =>[orig_patent_app_number] => 12568604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7685247 [patent_doc_number] => 20100120894 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-13 [patent_title] => 'Intracellular DNA receptor' [patent_app_type] => utility [patent_app_number] => 12/586662 [patent_app_country] => US [patent_app_date] => 2009-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 18838 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20100120894.pdf [firstpage_image] =>[orig_patent_app_number] => 12586662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8227280 [patent_doc_number] => 20120141488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-07 [patent_title] => 'NOVEL G PROTEIN COUPLED RECEPTOR PROTEIN AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/322304 [patent_app_country] => US [patent_app_date] => 2009-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15189 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13322304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6607794 [patent_doc_number] => 20100063260 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-03-11 [patent_title] => 'Whitefly Ecdysone Receptor Antibody' [patent_app_type] => utility [patent_app_number] => 12/553560 [patent_app_country] => US [patent_app_date] => 2009-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 30711 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0063/20100063260.pdf [firstpage_image] =>[orig_patent_app_number] => 12553560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7754459 [patent_doc_number] => 20120027683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'DIABETES T CELL RECEPTORS' [patent_app_type] => utility [patent_app_number] => 13/060230 [patent_app_country] => US [patent_app_date] => 2009-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 12036 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20120027683.pdf [firstpage_image] =>[orig_patent_app_number] => 13060230 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6024235 [patent_doc_number] => 20110052561 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'OSTEOLYSIS TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/549116 [patent_app_country] => US [patent_app_date] => 2009-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7699 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20110052561.pdf [firstpage_image] =>[orig_patent_app_number] => 12549116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10051808 [patent_doc_number] => 09091678 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-28 [patent_title] => 'Method for identifying compounds useful for treating and/or preventing disease-associated bone loss' [patent_app_type] => utility [patent_app_number] => 13/059446 [patent_app_country] => US [patent_app_date] => 2009-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 11 [patent_no_of_words] => 10883 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13059446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944045 [patent_doc_number] => 20110104665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'MUTANT SODIUM CHANNEL NAV 1.7 AND METHODS RELATED THERETO' [patent_app_type] => utility [patent_app_number] => 12/536245 [patent_app_country] => US [patent_app_date] => 2009-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 25539 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104665.pdf [firstpage_image] =>[orig_patent_app_number] => 12536245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6548967 [patent_doc_number] => 20100222410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-09-02 [patent_title] => 'Nuclease compositions and methods' [patent_app_type] => utility [patent_app_number] => 12/460446 [patent_app_country] => US [patent_app_date] => 2009-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 30197 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20100222410.pdf [firstpage_image] =>[orig_patent_app_number] => 12460446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7488628 [patent_doc_number] => 20110236907 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-29 [patent_title] => 'RADIOLABLED CYCLOPAMINE ASSAY FOR THE SMOOTHENED RECEPTOR' [patent_app_type] => utility [patent_app_number] => 12/999922 [patent_app_country] => US [patent_app_date] => 2009-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3545 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0236/20110236907.pdf [firstpage_image] =>[orig_patent_app_number] => 12999922 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5464977 [patent_doc_number] => 20090325177 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'Sensitive And Rapid Methods Of Using Chimeric Receptors To Identify Autoimmune Disease And Assess Disease Severity' [patent_app_type] => utility [patent_app_number] => 12/483689 [patent_app_country] => US [patent_app_date] => 2009-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 25293 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325177.pdf [firstpage_image] =>[orig_patent_app_number] => 12483689 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5374675 [patent_doc_number] => 20090312236 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'PEGYLATED INSULIN LISPRO COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/481111 [patent_app_country] => US [patent_app_date] => 2009-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 19823 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0312/20090312236.pdf [firstpage_image] =>[orig_patent_app_number] => 12481111 [rel_patent_id] =>[rel_patent_doc_number] =>)